Polymer-mediated immunocamouflage of red blood cells: Effects of polymer size on antigenic and immunogenic recognition of allogeneic donor blood cells

Science China Life Sciences

Volumn 54, Issue 7, 2011, Pages 589-598

  Wang, DunCheng ^a   Kyluik, Dana L ^a,b   Murad, Kari L ^c   Toyofuku, Wendy M ^a   Scott, Mark D ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c The College of Saint Rose   (United States)

Author keywords

alloimmunization; blood group antigens; erythrocyte; methoxypoly(ethylene glycol); mice

Indexed keywords

BLOOD GROUP ANTIGEN; DRUG CARRIER; MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENE GLYCOL;

ALLOTRANSPLANTATION; ANIMAL; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BAGG ALBINO MOUSE; BLOOD DONOR; C57BL MOUSE; CHEMISTRY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNIZATION; IMMUNOLOGY; METHODOLOGY; MOLECULAR WEIGHT; MOUSE; SHEEP;

AGGLUTINATION; ANIMALS; ANTIBODY FORMATION; BLOOD DONORS; BLOOD GROUP ANTIGENS; DRUG CARRIERS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR WEIGHT; POLYETHYLENE GLYCOLS; SHEEP; TRANSPLANTATION, HOMOLOGOUS;

MUS; OVIS ARIES;

EID: 79960109503     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-011-4190-x     Document Type: Article

References (36)

1. Walker R H, Lin D T, Hartwick M B. Alloimmunization following blood transfusion. Arch Pathol Lab Med, 1989, 113: 254-261.
2. Ambruso D R, Githens J H, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion, 1987, 27: 94-98.
3. Fluit C R, Kunst V A, Drenthe-Schonk A M. Incidence of red cell antibodies after multiple blood transfusion. Transfusion, 1990, 30: 532-535.
4. Vichinsky E P, Earles A, Johnson R A, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. New Eng J Med, 1990, 322: 1617-1621.
5. Michail-Merianou V, Pamphili-Panousopoulou L, Piperi-Lowes L, et al. Alloimmunization to red cell antigens in thalassemia: Comparative study of usual versus better-match transfusion programmes. Vox Sang, 1987, 52: 95-98.
6. McPherson M E, Anderson A R, Haight A E, et al. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor. Transfusion, 2009, 49: 1977-1986.
7. Shulman I A. Prophylactic phenotype matching of donors for the transfusion of nonalloimmunized patients with sickle cell disease. Immunohematology, 2006, 22: 101-102.
8. Castro O, Sandler S G, Houston-Yu P, et al. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: Theoretical and practical implications. Transfusion, 2002, 42: 684-690.
9. Scott M D, Murad K L, Koumpouras F, et al. Chemical camouflage of antigenic determinants: Stealth erythrocytes. Proc Natl Acad Sci USA, 1997, 94: 7566-7571.
10. Murad K L, Mahany K L, Brugnara C, et al. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood, 1999, 93: 2121-2127.
11. Bradley A J, Test S T, Murad K L, et al. Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs. Transfusion, 2001, 41: 1225-1233.
12. Bradley A J, Murad K L, Regan K L, et al. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: Size does matter. Biochim Biophys Acta, 2002, 1561: 147-158.
13. Bradley A J, Scott M D. Separation and purification of methoxypoly (ethylene glycol) grafted red blood cells via two-phase partitioning. J Chromatogr B Analyt Technol Biomed Life Sci, 2004, 807: 163-168.
14. Bradley A J, Scott M D. Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes. Am J Hematol, 2007, 82: 970-975.
15. Armstrong J K, Meiselman H J, Fisher T C. Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low shear blood viscosity. Am J Hematol, 1997, 56: 26-28.
16. Armstrong J K, Meiselman H J, Wenby R B, et al. Modulation of red blood cell aggregation and blood viscosity by the covalent attachment of Pluronic copolymers. Biorheology, 2001, 38: 239-247.
17. Hortin G L, Lok H T, Huang S T. Progress toward preparation of universal donor red cells. Artif Cells Blood Substit Immobil Biotechnol, 1997, 25: 487-491.
18. Tan Y, Qiu Y, Xu H, et al. Decreased immunorejection in unmatched blood transfusions by attachment of methoxypolyethylene glycol on human red blood cells and the effect on D antigen. Transfusion, 2006, 46: 2122-2127.
19. Tan Y, Ji S, Li S, et al. Comparative assessment of normal and methoxypolyethylene glycol-modified murine red cells on swimming endurance and hippocampal injury in hypoxic mice. Transfusion, 2008, 48: 1954-1958.
20. Le Y, Scott M D. Immunocamouflage: The biophysical basis of immunoprotection by grafted methoxypoly(ethylene glycol) (mpeg). Acta Biomater, 2010, 6: 2631-2641.
21. Chen A M, Scott M D. Immunocamouflage: Prevention of transfusion-induced graft-versus-host disease via polymer grafting of donor cells. J Biomed Mater Res A, 2003, 67: 626-636.
22. Chen A M, Scott M D. Comparative analysis of polymer and linker chemistries on the efficacy of immunocamouflage of murine leukocytes. Artif Cells Blood Substit Immobil Biotechnol, 2006, 34: 305-322.
23. Reid M E, Lomas-Francis C. The Blood Group Antigen Facts Book. San Diego: Academic Press, 2003.
24. Issitt P D. Race-related red cell alloantibody problems. Br J Biomed Sci, 1994, 51: 158-167.
25. Beattie K M, Shafer A W. Broadening the base of a rare donor program by targeting minority populations. Transfusion, 1986, 26: 401-404.
26. Thompson A A. Advances in the management of sickle cell disease. Pediatr Blood Cancer, 2006, 46: 533-539.
27. Martin S. Fundamentals of Immunology for Blood Bankers. In: Harmening DMMDS2708: F. A. Davis Company, 1994. 43-68.
28. Hughes-Jones N C, Gardner B, Lincoln P J. Observation of the number of available c, D, and E antigen sites on red cells. Vox Sang, 1971, 21: 210-216.
29. Masouredis S P, Sudora E, Mahan L, et al. Quatitative immunoferritin microscopy of Fy-a, Fy-b, Jk-a, U, and Di-b antigen site numbers on human red cells. Blood, 1980, 56: 969-977.
30. Skov F, Hughes-Jones N C. Observations on the number of available C antigen sites on red cells. Vox Sang, 1977, 33: 170-174.
31. Murad K L, Gosselin E J, Eaton J W, et al. Stealth cells: Prevention of major histocompatibility complex class II-mediated T-cell activation by cell surface modification. Blood, 1999, 94: 2135-2141.
32. Richter A W, Akerblom E. Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins. Int Arch Allergy Appl Immunol, 1983, 70: 124-131.
33. Richter A W, Akerblom E. Polyethylene glycol reactive antibodies in man: Titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors. Int Arch Allergy Appl Immunol, 1984, 74: 36-39.
34. Armstrong J K, Hempel G, Koling S, et al. Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. Cancer, 2007, 110: 103-111.
35. Garratty G. Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion. Vox Sang, 2008, 94: 87-95.
36. Sutton T C, Scott M D. The effect of grafted methoxypoly(ethylene glycol) chain length on the inhibition of respiratory syncytial virus (RSV) infection and proliferation. Biomaterials, 2010, 31: 4223-4230.